$1.63 EPS Expected for Raymond James Financial, Inc. (RJF); CareDx (CDNA) Has 6.14 Sentiment

April 20, 2018 - By Michael Collier

Raymond James Financial, Inc. (NYSE:RJF) Logo

CareDx (CDNA) investors sentiment increased to 6.14 in Q4 2017. It’s up 4.26, from 1.88 in 2017Q3. The ratio has increased, as 43 active investment managers opened new and increased stock positions, while 7 trimmed and sold positions in CareDx. The active investment managers in our database now own: 27.90 million shares, up from 6.43 million shares in 2017Q3. Also, the number of active investment managers holding CareDx in top ten stock positions increased from 1 to 4 for an increase of 3. Sold All: 3 Reduced: 4 Increased: 13 New Position: 30.

Analysts expect Raymond James Financial, Inc. (NYSE:RJF) to report $1.63 EPS on April, 25 after the close.They anticipate $0.35 EPS change or 27.34% from last quarter’s $1.28 EPS. RJF’s profit would be $229.62M giving it 13.50 P/E if the $1.63 EPS is correct. After having $1.61 EPS previously, Raymond James Financial, Inc.’s analysts see 1.24% EPS growth. The stock increased 1.65% or $1.43 during the last trading session, reaching $88.01. About 562,006 shares traded. Raymond James Financial, Inc. (NYSE:RJF) has risen 18.83% since April 20, 2017 and is uptrending. It has outperformed by 7.28% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $118,035 activity.

CareDx, Inc., together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company has market cap of $261.38 million. The firm operates through two divisions, CareDx and Olerup. It currently has negative earnings. The Company’s commercialized testing solution includes the AlloMap heart transplant molecular test , a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate/severe acute cellular rejection.

The stock decreased 1.53% or $0.14 during the last trading session, reaching $8.99. About 181,763 shares traded. CareDx, Inc (CDNA) has risen 402.58% since April 20, 2017 and is uptrending. It has outperformed by 391.03% the S&P500.

Analysts await CareDx, Inc (NASDAQ:CDNA) to report earnings on June, 8. They expect $-0.14 earnings per share, up 58.82% or $0.20 from last year’s $-0.34 per share. After $-0.11 actual earnings per share reported by CareDx, Inc for the previous quarter, Wall Street now forecasts 27.27% negative EPS growth.

Paragon Associates & Paragon Associates Ii Joint Venture holds 5.79% of its portfolio in CareDx, Inc for 948,000 shares. Gagnon Advisors Llc owns 955,758 shares or 5.14% of their US portfolio. Moreover, Gagnon Securities Llc has 4.89% invested in the company for 1.88 million shares. The Virginia-based Thompson Davis & Co. Inc. has invested 3.63% in the stock. Perkins Capital Management Inc, a Minnesota-based fund reported 178,639 shares.

Raymond James Financial, Inc., a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company has market cap of $12.40 billion. The firm operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other divisions. It has a 21.35 P/E ratio. The Private Client Group segment provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance products to their individual clients; and borrowing and lending of securities to and from other broker-dealers, financial institutions, and other counterparties.

Investors sentiment increased to 1.21 in 2017 Q4. Its up 0.18, from 1.03 in 2017Q3. It is positive, as 29 investors sold Raymond James Financial, Inc. shares while 139 reduced holdings. 60 funds opened positions while 143 raised stakes. 97.95 million shares or 0.86% more from 97.11 million shares in 2017Q3 were reported. Quantbot Technology L P accumulated 9,821 shares. Rainier Invest Mgmt Llc accumulated 1.73% or 45,940 shares. Blackrock holds 8.48 million shares or 0.04% of its portfolio. Employees Retirement Systems Of Texas stated it has 130,000 shares. Putnam Invests Ltd Liability Corp stated it has 0.01% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF). Yorktown Mgmt And Rech stated it has 3,500 shares or 0.09% of all its holdings. 4,497 are held by Richard Bernstein Advsrs Ltd Liability. Parkside Bancorp And Trust holds 0% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF) for 140 shares. Junto Mgmt Lp holds 3.29% or 482,607 shares in its portfolio. Ser Automobile Association invested in 0.01% or 48,845 shares. Strs Ohio holds 0.01% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF) for 17,996 shares. Clinton Gru Inc Inc has 0.05% invested in Raymond James Financial, Inc. (NYSE:RJF). 94,083 were reported by D E Shaw And. Howe And Rusling Incorporated accumulated 278 shares. Earnest Partners Ltd Co holds 1.75% of its portfolio in Raymond James Financial, Inc. (NYSE:RJF) for 2.05M shares.

Since December 11, 2017, it had 0 buys, and 8 selling transactions for $6.66 million activity. The insider REILLY PAUL C sold 12,681 shares worth $1.11M. Allison Paul D also sold $637,894 worth of Raymond James Financial, Inc. (NYSE:RJF) on Wednesday, March 14. Bunn James E also sold $288,930 worth of Raymond James Financial, Inc. (NYSE:RJF) on Tuesday, January 30. $455,000 worth of Raymond James Financial, Inc. (NYSE:RJF) shares were sold by ACKART JENNIFER C. 16,184 shares valued at $1.44 million were sold by TROCIN JEFFREY E on Monday, December 11. Elwyn Tashtego S sold 7,275 shares worth $708,327. Catanese George sold 506 shares worth $44,675.

Among 13 analysts covering Raymond James Financial Inc. (NYSE:RJF), 8 have Buy rating, 1 Sell and 4 Hold. Therefore 62% are positive. Raymond James Financial Inc. had 41 analyst reports since July 24, 2015 according to SRatingsIntel. On Friday, October 27 the stock rating was maintained by Buckingham Research with “Buy”. Wood maintained the stock with “Hold” rating in Thursday, May 25 report. On Thursday, January 25 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. Nomura maintained Raymond James Financial, Inc. (NYSE:RJF) rating on Thursday, July 13. Nomura has “Buy” rating and $90 target. The rating was downgraded by Nomura to “Neutral” on Monday, January 25. As per Friday, April 7, the company rating was maintained by Wood. The company was downgraded on Friday, October 28 by JMP Securities. Keefe Bruyette & Woods maintained Raymond James Financial, Inc. (NYSE:RJF) on Thursday, December 21 with “Hold” rating. The company was upgraded on Tuesday, February 27 by Wood. Credit Suisse maintained it with “Outperform” rating and $49 target in Monday, February 22 report.

Raymond James Financial, Inc. (NYSE:RJF) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts